Subsequent Events	12 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	NOTE 10 - subsequent events The Company evaluated all events or transactions that occurred after December 31, 2015, up through the date these consolidated financial statements were issued. Effective January 19, 2016, the Company issued 15,000 shares of common stock in a private placement for the receipt of $15,000. Effective January 19, 2016, the Company issued a warrant for the purchase of 15,000 shares of common stock at an exercise price of $1.50. There is no vesting period, and the warrants expire in one year. Effective March 1, 2016, the Company entered into an agreement with a consultant for accounting services and issued 50,000 common shares.

Subsequent Events

12 Months Ended

Dec. 31, 2015

NOTE 10 - subsequent events

The Company evaluated all events or transactions that occurred after December 31, 2015, up through the date these consolidated financial statements were issued.

Effective January 19, 2016, the Company issued 15,000 shares of common stock in a private placement for the receipt of $15,000.

Effective January 19, 2016, the Company issued a warrant for the purchase of 15,000 shares of common stock at an exercise price of $1.50. There is no vesting period, and the warrants expire in one year.

Effective March 1, 2016, the Company entered into an agreement with a consultant for accounting services and issued 50,000 common shares.

ARTVENTIVE MEDICAL GROUP, INC. 10-K